Authors: Hooker, Antony M.¹; Grdina, David J.²; Murley, Jeffrey S.²; Blyth, Benjamin J.¹; Ormsby, Rebecca J.¹; Bezak, Eva³; Giam, Kar A.⁴; Sykes, Pamela J.⁵

Source: International Journal of Low Radiation, Volume 6, Number 1, 29 May 2009 , pp. 43-56(14)

Publisher: Inderscience Publishers

Abstract:

Amifostine is a chemical radioprotector known to protect cells from DNA damage and toxicity normally induced by high-dose radiation exposure. Here, we used the sensitive in vivo pKZ1 mouse chromosomal inversion assay to determine the radioprotective effect of different doses of amifostine in the presence and absence of 250 mGy whole-body X-irradiation, the present radiation dose limit for radiation emergency workers. Amifostine was delivered intraperitoneally 3 h after radiation exposure and spleen tissue sections were analysed for inversions three days later. High doses of amifostine alone (100 and 400 mg/kg) protected from spontaneous chromosomal inversions, whereas 10 mg/kg had no effect and 1 mg/kg induced chromosomal inversions above the spontaneous inversion frequency. However, all doses of amifostine protected from chromosomal inversions normally induced by 250 mGy X-radiation, with the highest doses also protecting from spontaneous inversions. The pattern of chromosomal inversion responses observed here with amifostine is remarkably similar to that observed in our previous studies using single low-dose and two-dose whole-body X-radiation. These results indicate that the reductive as well as other cellular endogenous prosurvival mechanisms associated with amifostine radioprotection will likely play a role in low-dose radiation-induced protection.

Keywords: ENVIRONMENTAL JOURNALS; Environment and Sustainable Development; HEALTHCARE AND LEISURE JOURNALS; Healthcare and Medical Engineering; ENVIRONMENTAL JOURNALS; Nuclear Science and Technology

Document Type: Research article

DOI: http://dx.doi.org/10.1504/IJLR.2009.026239

Affiliations: 1: Department of Haematology and Genetic Pathology, Flinders University and Medical Centre, Bedford Park, South Australia, 5042, Australia. 2: Department of Radiation and Cellular Oncology, University of Chicago, Chicago, IL 60367, USA. 3: Department of Medical Physics, Royal Adelaide Hospital, Adelaide, South Australia, 5000, Australia. 4: Department of Radiation Oncology, Royal Adelaide Hospital, Adelaide, South Australia, 5000, Australia. 5: Department of Haematology and Genetic Pathology, SA Pathology, Flinders University and Medical Centre, Bedford Park, South Australia, 5042, Australia

Publication date: 2009-05-29

More about this publication?

• The International Journal of Low Radiation is a peer-reviewed journal dedicated to the publication of research articles, review papers and technical notes in all domains related to low-dose radiation, among which are the biological and health effects in humans and the biota, in vitro and in vivo research on low radiation effects, regulatory and policy aspects, risk estimation and public perception.
• Information for Authors
• Submit a Paper
• Subscribe to this Title
• Terms & Conditions
• Newsletter
• Blog
• ingentaconnect is not responsible for the content or availability of external websites

Related content

• In this: publication
• By this: publisher
• In this Subject: Medicine ,  Physics (General)
• By this author: Hooker, Antony M. ;  Grdina, David J. ;  Murley, Jeffrey S. ;  Blyth, Benjamin J. ;  Ormsby, Rebecca J. ;  Bezak, Eva ;  Giam, Kar A. ;  Sykes, Pamela J.

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers